Michel Eid Farah

Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)

Lihteh Wu, María Ana Martinez-Castellanos, Hugo Quiroz–Mercado et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2007 · 457 citations

Medicine, Ophthalmology, Surgery +16

Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy

J. Fernando Arévalo, Maurício Maia, Harry W. Flynn et al. · British Journal of Ophthalmology · 2007 · 408 citations

Medicine, Ophthalmology, Surgery +11

Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema

J. Fernando Arévalo, Jans Fromow-Guerra, Hugo Quiroz–Mercado et al. · Ophthalmology · 2007 · 337 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +13

Randomized Clinical Trial Evaluating mETDRS versus Normal or High-Density Micropulse Photocoagulation for Diabetic Macular Edema

Daniel Lavinsky, J.A. Cardillo, Luiz Alberto S. Melo et al. · Investigative Ophthalmology & Visual Science · 2011 · 222 citations · Full text

Health Professions, Ophthalmology, Optometry +17

Comparison of Intravitreal versus Posterior Sub–Tenon’s Capsule Injection of Triamcinolone Acetonide for Diffuse Diabetic Macular Edema

J.A. Cardillo, Luiz Alberto S. Melo, Rogério A. Costa et al. · Ophthalmology · 2005 · 149 citations

Pharmacy, Ophthalmology, Pharmacotherapy +12